» Articles » PMID: 29594119

Monogenic Causes of Proteinuria in Children

Overview
Specialty General Medicine
Date 2018 Mar 30
PMID 29594119
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Glomerular disease is a common cause for proteinuria and chronic kidney disease leading to end-stage renal disease requiring dialysis or kidney transplantation in children. Nephrotic syndrome in children is diagnosed by the presence of a triad of proteinuria, hypoalbuminemia, and edema. Minimal change disease is the most common histopathological finding in children and adolescents with nephrotic syndrome. Focal segmental sclerosis is also found in children and is the most common pathological finding in patients with monogenic causes of nephrotic syndrome. Current classification system for nephrotic syndrome is based on response to steroid therapy as a majority of patients develop steroid sensitive nephrotic syndrome regardless of histopathological diagnosis or the presence of genetic mutations. Recent studies investigating the genetics of nephrotic syndrome have shed light on the pathophysiology and mechanisms of proteinuria in nephrotic syndrome. Gene mutations have been identified in several subcellular compartments of the glomerular podocyte and play a critical role in mitochondrial function, actin cytoskeleton dynamics, cell-matrix interactions, slit diaphragm, and podocyte integrity. A subset of genetic mutations are known to cause nephrotic syndrome that is responsive to immunosuppressive therapy but clinical data are limited with respect to renal prognosis and disease progression in a majority of patients. To date, more than 50 genes have been identified as causative factors in nephrotic syndrome in children and adults. As genetic testing becomes more prevalent and affordable, we expect rapid advances in our understanding of mechanisms of proteinuria and genetic diagnosis will help direct future therapy for individual patients.

Citing Articles

Pediatric nephrologists' perspectives and clinical practices related to genetic testing and education.

Fernandez H, Lipton M, Balderes O, Lin F, Marasa M, Rasouly H Pediatr Nephrol. 2024; 40(3):755-763.

PMID: 39382664 PMC: 11745921. DOI: 10.1007/s00467-024-06539-7.


Multidisciplinary approach in diagnosis and treatment of Fong disease.

Gecheva N, Angelov V, Kaneva R, Dikova M J Surg Case Rep. 2024; 2024(4):rjae207.

PMID: 38605702 PMC: 11007641. DOI: 10.1093/jscr/rjae207.


Diagnosis delay a family of Galloway-Mowat Syndrome caused by a classical splicing mutation of Lage3.

Chen Y, Yang Y, Yang Y, Rao J, Bai H BMC Nephrol. 2023; 24(1):29.

PMID: 36755238 PMC: 9909869. DOI: 10.1186/s12882-022-03000-5.


Establishment of relapse risk model and multivariate logistic regression analysis on risk factors of relapse in children with primary nephrotic syndrome.

Peng Q, Zeng P, Jiang X, Guan F Medicine (Baltimore). 2022; 101(29):e29866.

PMID: 35866787 PMC: 9302243. DOI: 10.1097/MD.0000000000029866.


Ascites in infantile onset type II Sialidosis.

Tazi K, Guy-Viterbo V, Gheldof A, Empain A, Paternoster A, De Laet C JIMD Rep. 2022; 63(4):316-321.

PMID: 35822090 PMC: 9259393. DOI: 10.1002/jmd2.12305.


References
1.
Trautmann A, Bodria M, Ozaltin F, Gheisari A, Melk A, Azocar M . Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort. Clin J Am Soc Nephrol. 2015; 10(4):592-600. PMC: 4386250. DOI: 10.2215/CJN.06260614. View

2.
Gbadegesin R, Winn M, Smoyer W . Genetic testing in nephrotic syndrome--challenges and opportunities. Nat Rev Nephrol. 2013; 9(3):179-84. PMC: 3702380. DOI: 10.1038/nrneph.2012.286. View

3.
Antignac C . Genetic models: clues for understanding the pathogenesis of idiopathic nephrotic syndrome. J Clin Invest. 2002; 109(4):447-9. PMC: 150884. DOI: 10.1172/JCI15094. View

4.
Machuca E, Benoit G, Antignac C . Genetics of nephrotic syndrome: connecting molecular genetics to podocyte physiology. Hum Mol Genet. 2009; 18(R2):R185-94. DOI: 10.1093/hmg/ddp328. View

5.
Ruf R, Lichtenberger A, Karle S, Haas J, Anacleto F, Schultheiss M . Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. J Am Soc Nephrol. 2004; 15(3):722-32. DOI: 10.1097/01.asn.0000113552.59155.72. View